PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Here, in the hope of enhancing our understanding of NAFLD-HCC in a clinically translatable fashion, we have explored SNPs in a number of candidate HCC immunoregulatory genes, in addition to those in PNPLA3 and TM6SF2, in patients with NAFLD and NAFLD-HCC.